Outcomes Following Mycophenolate Mofetil Versus Cyclophosphamide Induction Treatment for Proliferative Juvenile-Onset Lupus Nephritis

Lupus - United Kingdom
doi 10.1177/0961203319836712
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

SAGE Publications

Related search

Cyclophosphamide Versus Mycophenolate Mofetil for Initial Treatment of Lupus Nephritis

Kidney International
Nephrology
2013English

Comparative Effectiveness of Mycophenolate Mofetil for the Treatment of Childhood-Onset Proliferative Lupus Nephritis

Arthritis Care and Research
Rheumatology
2017English

Leflunomide Versus Cyclophosphamide in the Induction Treatment of Proliferative Lupus Nephritis in Chinese Patients: A Randomized Trial

Clinical Rheumatology
MedicineRheumatology
2018English

Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2007English

81 Outcomes of Multi-Target Therapy Using Mycophenolate Mofetil and Tacrolimus for Refractory Lupus Nephritis

2017English

Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis With Poor Kidney Function: A Subgroup Analysis of the Aspreva Lupus Management Study

American Journal of Kidney Diseases
Nephrology
2013English

Efficacy of High-Dose Mycophenolate Mofetil in Multitarget Therapy for Lupus Nephritis: Two Consecutive Case Reports

Cureus
2020English

254 Induction and Maintenance Treatment of Proliferative Lupus Nephritis: An Updated Cochrane Review

2017English

Intravenous Cyclophosphamide Combined With Steroids in Pediatric Onset Severe Lupus Nephritis

International Urology and Nephrology
UrologyNephrology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy